ESC Premium Access

What is the impact on clinical practice of low-risk TAVI trials?

Topic: Diseases of the Aorta, Other
Sponsored by Medscape Education Global

Congress Presentation

About the speaker

Associate Professor Giuseppe Tarantini

University of Padua, Padova (Italy)
9 presentations
1 follower

5 more presentations in this session

Welcome and introductions

Speaker: Professor L. Pierard (Liege, BE)


Asymptomatic patients at risk with severe aortic stenosis

Speaker: Professor L. Pierard (Liege, BE)


Clinical case - A low surgical risk patient undergoing TAVI

Speaker: Professor T. Modine (Bordeaux, FR)


Do valve hemodynamic function and durability matter?

Speaker: Professor P. Pibarot (Quebec, CA)


Questions and answers and panel discussion

Speaker: Professor L. Pierard (Liege, BE)


Access the full session

Impact of low-surgical-risk TAVI trials on clinical decision making

Speakers: Associate Professor G. Tarantini, Professor L. Pierard, Professor L. Pierard, Professor T. Modine, Professor P. Pibarot...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb